Selank
Selank (Tuftsin Analogue)
Anxiolytic and nootropic with immune modulation
How it works
Selank modulates the expression of IL-6 and other cytokines and increases BDNF expression. It has GABAergic activity that produces anxiolytic effects, while simultaneously enhancing cognitive processing through monoamine system modulation.
What the research explores
In published research, Selank has been studied in connection with the following. These describe findings reported in the literature — not approved uses, claims, or outcomes to expect.
- Reduces anxiety without causing sedation or dependence
- Improves working memory and cognitive clarity
- Modulates immune function via IL-6 and IL-1beta
- Elevates BDNF similarly to Semax
- Antidepressant-like properties
- Approved in Russia for anxiety disorders
Selank outperformed benzodiazepines in controlled Russian trials for generalized anxiety disorder while producing no sedation, motor impairment, or withdrawal symptoms.
Adverse events & gaps
No addictive potential, no withdrawal. Very favorable safety profile in Russian clinical use.
Stay Informed on
Peptide Research
Research summaries, newly documented peptides, and clinical trial updates delivered to your inbox.
No spam. Unsubscribe at any time.